Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Molecular Imaging and Biology|September 23, 2003
Image-derived input function for [11C]flumazenil kinetic analysis in human brainSandra M Sanabria-Bohórquez, Alex Maes, Patrick Dupont, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 11, 2017
cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tanglesThomas Lee Collier, Daniel L Yokell, Eli Livni, et al.
Clinical & Experimental Metastasis|February 26, 2022
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphologyShuncong Wang, Lei Chen, Yuanbo Feng, et al.
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
[11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeuticsRomy Cools, Valeria Narykina, Koen Vermeulen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brainSofie Celen, Michel Koole, Meri De Angelis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2025
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's diseaseAline Delva, Michel Koole, Kim Serdons, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 22, 2025
Dosimetry and kinetic modelling of [18F]JNJ-64511070, a novel PET ligand to quantify AMPA-associated TARP-γ8 receptors in the human brainMichel Koole, Mark E Schmidt, Anja Hijzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2020
Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brainMichel Koole, Donatienne Van Weehaeghe, Kim Serdons, et al.
Oncotarget|September 15, 2017
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4PYewei Liu, Ting Yin, Frederik De Keyzer, et al.
Pageof 23